UroGen Pharma LtdEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 40.45 USD | 43,93 USD | 15,86 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 44,75 USD | 5 | 1 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 48.721.701 | 11,91 | 7,53 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name UroGen Pharma Ltd
Mitarbeiter 298
Handelsplatz NASDAQ
Ticker Symbol URGN
IPO Datum 2017-05-04
Adresse 400 Alexander Park Drive, Princeton, NJ, United States, 08540
Webseite https://www.urogen.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Ms. Elizabeth A. Barrett | President, CEO & Director |
| 2 | Mr. Jason Drew Smith J.D. | General Counsel, Chief Compliance Officer & Corporate Secretary |
| 3 | Dr. Mark P. Schoenberg M.D. | Chief Medical Officer |
| 4 | Mr. Christopher Degnan CPA | Chief Financial Officer |
| 5 | Mr. Vincent I. Perrone | Senior Director of Investor Relations |
| 6 | Ms. Alison Hardgrove | Senior Vice President of Human Resources |
| 7 | Dr. Marina Konorty Ph.D. | Executive Vice President of Research & Development and Technical Operations |
| 8 | Mr. James Ottinger R.ph. | Executive Vice President of Regulatory Affairs & Quality |
| 9 | Mr. Michael J. Louie M.D., M.P.H., M.Sc. | Chief Development Officer |
| 10 | Mr. Timothy Simon | Senior Vice President of Business Development & Portfolio Strategy |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | RTW INVESTMENTS, LLC | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | The Toronto-Dominion Bank | 0,00% | 0,00 Mio. USD |
| 4 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 5 | Kynam Capital Management, LP | 0,00% | 0,00 Mio. USD |
| 6 | Jefferies Financial Group Inc | 0,00% | 0,00 Mio. USD |
| 7 | Paradigm Biocapital Advisors LP | 0,00% | 0,00 Mio. USD |
| 8 | SG Americas Securities, LLC | 0,00% | 0,00 Mio. USD |
| 9 | American Century Companies Inc | 0,00% | 0,00 Mio. USD |
| 10 | SILVERARC CAPITAL MANAGEMENT, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Opaleye Management Inc | 0,00% | 0,00 Mio. USD |
| 12 | Frontier Capital Management CO Inc | 0,00% | 0,00 Mio. USD |
| 13 | MENORA MIVTACHIM HOLDINGS LIMITED | 0,00% | 0,00 Mio. USD |
| 14 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 15 | MPM Oncology Impact Management LP | 0,00% | 0,00 Mio. USD |
| 16 | J. Goldman & Co LP | 0,00% | 0,00 Mio. USD |
| 17 | Orbimed Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 18 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 19 | Migdal Insurance & Financial Holdings Ltd | 0,00% | 0,00 Mio. USD |
| 20 | Soleus Capital Management, L.P. | 0,00% | 0,00 Mio. USD |